⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,837.05
−0.25%
FTSE ADX
9,859.88
+0.78%
TASI
9,975.48
−1.46%
QE Index
8,576.87
−0.65%
S&P 500
7,690.73
+0.41%
Nasdaq 100
29,529.34
+1.17%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,854.48
−0.07%
DFM:EMIRATESNBD
AED 31.50
+0.00%
ADX:IHC
AED 360.00
+2.27%
SAU:2222
SAR 25.72
−0.31%
DSMD:QNBK
QAR 15.49
−1.09%
NAS:NVDA
$217.09
+1.38%
NYSE:TSM
$420.22
+1.84%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 300.15
+0.23%
Gold
$4,125.92
−0.36%
Brent
$110.56
+1.22%
BTC
$81,465.28
−0.46%
ETH
$2,388.90
−0.68%
DFM General
5,837.05
−0.25%
FTSE ADX
9,859.88
+0.78%
TASI
9,975.48
−1.46%
QE Index
8,576.87
−0.65%
S&P 500
7,690.73
+0.41%
Nasdaq 100
29,529.34
+1.17%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,854.48
−0.07%
DFM:EMIRATESNBD
AED 31.50
+0.00%
ADX:IHC
AED 360.00
+2.27%
SAU:2222
SAR 25.72
−0.31%
DSMD:QNBK
QAR 15.49
−1.09%
NAS:NVDA
$217.09
+1.38%
NYSE:TSM
$420.22
+1.84%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 300.15
+0.23%
Gold
$4,125.92
−0.36%
Brent
$110.56
+1.22%
BTC
$81,465.28
−0.46%
ETH
$2,388.90
−0.68%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Open
🇸🇦
Saudi Arabia
Tadawul · TASI
Open
🇶🇦
Qatar
QSE · QE General
Open
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Closed
🇮🇳
India
NSE · BSE · Nifty 50
Closed
🇵🇰
Pakistan
PSX · KSE-100
Open
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
Bristol-Myers Squibb Co · News · TradingHolo
Markets
›
United States
› NYSE
› BMY
B
Bristol-Myers Squibb Co
NYSE:BMY
Healthcare
CBOE:SPESG
STOXX:EDD24BP
$58.83
−1.54%
At close
At close · Tue 20 Oct · ≈
AED 216.05
· Market cap
$120.17B
· Next earnings
Thu 29 Oct
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
Ownership
Options
Shorts
News
Profile
BMY news
Headlines tagged to this company
SE
FDA launches pilot program that aims to speed the time to first-in-human drug trials
seekingalpha · 35 d ago
SE
AM Markets Need to Know: Diesel tops $6, DeepSeek pressures chips, and more
seekingalpha · 39 d ago
SE
Trump's surgeon general pick discloses tobacco, fast food and soda investments
seekingalpha · 39 d ago
ZA
BMY Gains 19.4% Year to Date: Should You Buy, Sell or Hold the Stock?
zacks · 40 d ago
SE
25 dividend stocks to watch as market sentiment turns negative
seekingalpha · 41 d ago
ZA
Will The Recent Pipeline Progress Boost BMY's Portfolio Expansion?
zacks · 41 d ago
SE
Ten healthcare stocks with A-rated valuations and strong revenue growth
seekingalpha · 41 d ago
BE
Bristol Myers Says Cell Therapy Shows Promise For Heavily Pretreated Blood Cancer Patients
benzinga · 42 d ago
BA
Bristol Myers Swoons on Test Results
baystreet · 42 d ago
ZA
Here's Why Bristol Myers Squibb (BMY) is a Strong Value Stock
Zacks Investment Research · 62 d ago
ZA
Can BMY's First CELMoD Approval Support Its Growth Strategy?
Zacks Investment Research · 67 d ago
BU
U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ZENBEXUS™, in Combination with Daratumumab and Hyaluronidase-fihj and Dexamethasone (ZDd) for Patients with Multiple Myeloma, as Early as First Relapse
Business Wire · 68 d ago
RE
US FDA approves Bristol Myers' blood cancer treatment
Reuters · 68 d ago
RE
Lawsuit against Bristol Myers over delayed cancer drug is revived
Reuters · 68 d ago
ZA
Is BMY's Growth Portfolio Strong Enough to Offset Legacy Drug Declines?
Zacks Investment Research · 69 d ago
ZA
BMY Rallies 16.2% in Three Months: Buy, Sell or Hold the Stock?
Zacks Investment Research · 71 d ago
BU
Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas
Business Wire · 71 d ago
ZA
Bristol Myers (BMY) Moves to Buy: Rationale Behind the Upgrade
Zacks Investment Research · 75 d ago
← Previous
End of the feed